Volatile Biomarkers for Health Monitoring
-
Parkinson’s disease (PD), the second most common progressive neurodegenerative disease, develops and progresses for 10-15 years or more before the clinical diagnostic symptoms of the disease occur. Finding reliable, specific, and highly predictive biomarkers during the latent period of the disease is a substantial challenge for the success of PD curative or preventive strategies and…
We recruit. [email protected]